EQ : Insider Transactions for Equillium Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Equillium Inc (EQ)

$0.00 0.00 (0.00%) as of 4:30 Fri 2/14

Download

Exchange:

N/A

Security Type:

Common

Shares Out:

24,730,000

Market Cap:

N/A

Last Volume:

0

Avg Vol:

0

52 Week Range:

$0 - $0

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -

Company Profile Equillium is a clinical-stage biotechnology company to develop therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. Co.'s pipeline is focused on developing itolizumab (EQ001), EQ101 and EQ102 as potential disease modifying treatments for multiple severe immuno-inflammatory disorders. Co. has active clinical development programs for itolizumab (EQ001) for the treatment of acute graft-versus-host disease and lupus/lupus nephritis. Co. also has a proprietary product discovery platform that it can utilize to design peptides to target and inhibit multiple cytokines that are involved in validated biological and disease pathways.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	0	0	0	12,000
Total Sell Value	$0	$0	$0	$32,410
Total People Sold	0	0	0	1
Total Sell Transactions	0	0	0	2
End Date	2024-01-28	2023-10-27	2023-04-28	2022-04-28

Adjust Filter Settings

Records found: 51

Page 1 of 3

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Principal Accounting Officer

• – –

2024-03-06

3

IO

$0.00

$0

D/D

0

33,857

-

Chief Financial Officer

• – –

2023-12-08

4

A

$0.58

$5,107

D/D

8,805

58,913

-

Zedelmayer Christine

Sr. Vice President and COO

• – –

2023-12-08

4

A

$0.58

$5,106

D/D

8,804

135,246

-

Chief Development Officer

• – –

2023-12-08

4

A

$0.58

$5,106

D/D

8,804

58,150

-

Chief Financial Officer

• – –

2023-06-09

4

A

$0.56

$8,400

D/D

15,000

50,108

-

Zedelmayer Christine

Sr. Vice President and COO

• – –

2023-06-09

4

A

$0.56

$8,400

D/D

15,000

126,442

-

Chief Development Officer

• – –

2023-06-09

4

A

$0.56

$8,400

D/D

15,000

49,346

-

Chief Development Officer

• – –

2022-12-09

4

A

$1.19

$4,547

D/D

3,821

34,346

-

Chief Financial Officer

• – –

2022-12-09

4

A

$1.19

$5,288

D/D

4,444

35,108

-

Chief Financial Officer

• – –

2022-08-29

4

AS

$2.83

$19,810

I/I

(7,000)

77,720

-

Zedelmayer Christine

Sr. Vice President and COO

• – –

2022-06-10

4

A

$1.85

$16,711

D/D

9,033

111,442

-

Chief Development Officer

• – –

2022-06-10

4

A

$1.85

$11,551

D/D

6,244

30,525

-

Chief Financial Officer

• – –

2022-06-06

4

AS

$2.52

$12,600

I/I

(5,000)

84,720

-

Chief Financial Officer

• – –

2022-04-04

4

AS

$3.18

$25,440

I/I

(8,000)

89,720

-

Chief Financial Officer

• – –

2021-12-10

4

A

$2.35

$13,125

D/D

5,585

23,296

-

Chief Development Officer

• – –

2021-12-10

4

A

$2.35

$3,032

D/D

1,290

24,281

-

Chief Financial Officer

• – –

2021-12-01

4

AS

$5.08

$25,402

I/I

(5,000)

97,720

-

Zedelmayer Christine

Sr. Vice President and COO

• – –

2021-11-16

4

AS

$5.49

$62,715

D/D

(11,434)

102,409

-

Zedelmayer Christine

Sr. Vice President and COO

• – –

2021-11-16

4

OE

$2.45

$57,168

D/D

23,334

109,759

-

Connelly Stephen

Chief Scientific Officer

• • –

2021-10-06

4

AS

$7.01

$56,706

D/D

(8,092)

993,000

-

Connelly Stephen

Chief Scientific Officer

• • –

2021-10-06

4

OE

$2.80

$33,626

D/D

8,092

995,467

-

Chief Financial Officer

• – –

2021-09-27

4

AS

$6.74

$53,924

I/I

(8,000)

102,720

-

Chief Financial Officer

• – –

2021-07-27

4

AS

$5.72

$28,585

I/I

(5,000)

110,720

-

Zedelmayer Christine

Sr. Vice President and COO

• – –

2021-06-10

4

A

$2.35

$21,225

D/D

9,032

90,509

-

Chief Financial Officer

• – –

2021-06-10

4

A

$2.35

$13,007

D/D

5,535

17,711

-

51 Records found	1 2 3	Page 1 of 3

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.